The Science of Cannabis.
Unfiltered.
We're an independent, scientist-led platform dedicated to making peer-reviewed cannabis research accessible — without the hype, the advocacy, or the industry spin.
*Based on independent editorial audits. See methodology.
Why We Built This
Cannabis is one of the most researched — and most misrepresented — substances in modern medicine. Patients, clinicians, and policymakers deserve a resource that reflects the actual state of the science.
The Problem
- ✗Industry-funded studies overstating benefits
- ✗Anti-cannabis advocacy cherry-picking harms
- ✗Journalists misrepresenting preliminary findings
- ✗Patients making decisions based on anecdotes
- ✗Clinicians lacking reliable, current summaries
- ✗Primary literature locked behind paywalls
Our Solution
- Peer-reviewed studies only, no industry white papers
- Transparent evidence grading on every summary
- No funding from cannabis or pharmaceutical companies
- Plain-language summaries reviewed by MDs and PhDs
- Free public access to core research content
- Corrections published prominently when errors occur
Our Editorial Principles
Six commitments that govern every piece of content on this platform.
Peer-Reviewed Only
We index only studies published in peer-reviewed journals. No anecdotes, no industry white papers, no unreviewed preprints without clear labeling.
No Financial Conflicts
We accept no funding from cannabis companies, pharmaceutical manufacturers, or advocacy organizations. Our editorial decisions are made independently.
Transparent Evidence Grading
Every study and summary carries an evidence level — Well-Studied, Emerging, or Limited — based on study quality, sample size, and replication. Read our evidence standards →
Nuance Over Narrative
Cannabis science is complex and often contradictory. We present the full picture — including null results, limitations, and conflicting findings.
Accessible to Everyone
Core research summaries and Q&A are free and publicly accessible. Science shouldn't be locked behind paywalls for patients who need it.
Medical Accuracy First
All clinical content is reviewed by licensed physicians and PhD-level scientists before publication. We correct errors promptly and transparently.
Scientific Leadership
Our editorial team combines decades of bench research, clinical practice, and science communication.
Dr. Sarah Chen, PhD
Founder & Scientific Director
PhD Pharmacology, Johns Hopkins · Former NIH Research Fellow
Dr. Chen spent 12 years as a bench researcher studying cannabinoid receptor pharmacology before founding MarijuanaResearch.com. Her work has been published in Nature, JAMA, and Neuropsychopharmacology.
Dr. Marcus Webb, MD
Medical Director
MD, UCSF · Board Certified Internal Medicine · Cannabis Medicine Specialist
Dr. Webb brings clinical perspective to the platform, ensuring research summaries are accurate and clinically relevant. He maintains an active practice and consults for hospital systems on medical cannabis protocols.
Dr. Priya Nair, PhD
Head of Research Curation
PhD Neuroscience, Stanford · Former Postdoc, Salk Institute
Dr. Nair leads the team responsible for indexing, reviewing, and summarizing incoming research. She developed the evidence-level classification system used across the platform.
James Okafor, MPH
Public Health & Policy Lead
MPH, Harvard T.H. Chan School of Public Health
James ensures the platform serves public health goals — translating complex science into accessible language for patients, caregivers, and policymakers without sacrificing accuracy.
What the Medical Community Says
"The most rigorous cannabis research database available to the public."
"A model for how to communicate complex pharmacology to non-specialist audiences."
"Clinicians trust MarijuanaResearch.com precisely because it doesn't oversell the evidence."
"Fills a critical gap between primary literature and patient-facing misinformation."
How We're Funded
MarijuanaResearch.com is funded through a combination of reader subscriptions, institutional licensing fees, and grants from non-partisan medical research foundations. We do not accept advertising, sponsored content, or funding from cannabis companies, pharmaceutical manufacturers, or advocacy organizations on either side of the policy debate.
Our full funding disclosures, donor list, and conflict-of-interest policies are published annually in our transparency report.
Get in Touch
For press inquiries, research submissions, corrections, or institutional licensing, reach our editorial team directly.
Explore the Research Library